ArticleGynecologic oncology reports2024

Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer.

Michelle Greenman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.